The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
New developments in the genetics, pathogenesis, and therapy of IgA nephropathy
Open accessAbstract
Recent years have brought notable progress in the field of IgA nephropathy. Here, we highlight important new directions and latest developments, including successful discovery of several genetic susceptibility loci, formulation of the multi-hit pathogenesis model that integrates findings from studies of galactose-deficient IgA1, anti-glycan response and immune complex-induced kidney injury, introduction of the Oxford pathology scoring system, and formalization of the Kidney Disease Improving Global Outcomes (KDIGO) consensus treatment guidelines. We focus on the latest genetic findings that confirm a strong contribution of inherited factors and explain some of the geo-ethnic disparities in disease susceptibility. Most IgA nephropathy susceptibility loci discovered to date encode genes involved in the maintenance of the intestinal epithelial barrier and response to mucosal pathogens. The concerted pattern of inter-population allelic differentiation across all Genome Wide Association Studies (GWAS) loci parallels the disease prevalence and correlates with variation in local pathogens, suggesting that multi-locus adaptation might have shaped the present-day landscape of IgA nephropathy. Importantly, the “Intestinal Immune Network for IgA Production” emerged as one of the new targets for potential therapeutic intervention. We place these findings in the context of the multi-hit pathogenesis model and existing knowledge of IgA immunobiology. Lastly, we provide our perspective on the existing treatment options, discuss areas of clinical uncertainty, and outline ongoing clinical trials and translational studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P., & Cerutti, A. (2002) · Nature Immunology · doi:10.1038/ni829 · Cited by 1,252
Retracted2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Jennette, J. C., Falk, R. J., Bacon, P. A., Basu, N., Cid, M. C., Ferrario, F., Flores‐Suarez, L. F., Gross, W. L., Guillevin, L., Hagen, E. C., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37715 · Cited by 6,631
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
Stone, J. H., Merkel, P. A., Spiera, R., Seo, P., Langford, C. A., Hoffman, G. S., Kallenberg, C. G. M., St. Clair, E. W., Turkiewicz, A., Tchao, N. K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909905 · Cited by 2,762
Franke, A., McGovern, D. P. B., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., et al. (2010) · Nature Genetics · doi:10.1038/ng.717 · Cited by 2,520
Visscher, P. M., Brown, M. A., McCarthy, M. I., & Yang, J. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.029 · Cited by 2,425
Personal genomes: The case of the missing heritability
Maher, B. (2008) · Nature · doi:10.1038/456018a · Cited by 1,737
Transglutaminases: crosslinking enzymes with pleiotropic functions
Lorand, L., & Graham, R. M. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1014 · Cited by 1,438
Global numbers of infection and disease burden of soil transmitted helminth infections in 2010
Pullan, R. L., Smith, J. L., Jasrasaria, R., & Brooker, S. J. (2014) · Parasites & Vectors · doi:10.1186/1756-3305-7-37 · Cited by 1,418
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International Multiple Sclerosis Genetics Consortium (IMSGC) (2013) · Nature Genetics · doi:10.1038/ng.2770 · Cited by 1,386
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Kallenberg, C. G. M., Lamprecht, P., Hoffman, G. C., Rasmussen, N., Pusey, C. D., Özen, S., Matteson, E. L., Merkel, P. A., Flores-Suarez, L. F., Bacon, P. A., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/tnnw-jw94 · Cited by 1,255
A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran, D. C., Coppo, R., Cook, H. T., Feehally, J., Roberts, I. S. D., Troyanov, S., Alpers, C. E., Amore, A., Barratt, J., et al. (2009) · Kidney International · doi:10.1038/ki.2009.243 · Cited by 1,235
Self-citationA Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts, I. S. D., Cook, H. T., Troyanov, S., Alpers, C. E., Amore, A., Barratt, J., Berthoux, F., Bonsib, S., Bruijn, J. A., et al. (2009) · Kidney International · doi:10.1038/ki.2009.168 · Cited by 1,038
Self-citation(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.9 · Cited by 966
Association of Systemic Lupus Erythematosus with C8orf13–BLK and ITGAM–ITGAX
Hom, G., Graham, R. R., Modrek, B., Taylor, K. E., Ortmann, W., Garnier, S., Lee, A. T., Chung, S. A., Ferreira, R. C., Pant, P. V. K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707865 · Cited by 914
The Pathophysiology of IgA Nephropathy
Suzuki, H., Kiryluk, K., Novak, J., Moldoveanu, Z., Herr, A. B., Renfrow, M. B., Wyatt, R. J., Scolari, F., Mestecky, J., Gharavi, A. G., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011050464 · Cited by 910
Self-citationKDIGO Clinical Practice Guideline for Glomerulonephritis
Eckardt, K., & Kasiske, B. L. (2012) · Cited by 893
National Institute of Diabetes and Digestive Kidney Diseases Inflammatory Bowel Disease Genetics Consortium (NIDDK IBDGC), Rivas, M. A., United Kingdom Inflammatory Bowel Disease Genetics Consortium, International Inflammatory Bowel Disease Genetics Consortium, Beaudoin, M., Gardet, A., Stevens, C., Sharma, Y., Zhang, C. K., Boucher, G., et al. (2011) · Nature Genetics · doi:10.1038/ng.952 · Cited by 771
Uematsu, S., Fujimoto, K., Jang, M. H., Yang, B.-G., Jung, Y.-J., Nishiyama, M., Sato, S., Tsujimura, T., Yamamoto, M., Yokota, Y., et al. (2008) · Nature Immunology · doi:10.1038/ni.1622 · Cited by 745
He, B., Xu, W., Santini, P. A., Polydorides, A. D., Chiu, A., Estrella, J., Shan, M., Chadburn, A., Villanacci, V., Plebani, A., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.04.014 · Cited by 745
Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
Specks, U., Merkel, P. A., Seo, P., Spiera, R., Langford, C. A., Hoffman, G. S., Kallenberg, C. G. M., St. Clair, E. W., Fessler, B. J., Ding, L., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213277 · Cited by 728
TACI is mutant in common variable immunodeficiency and IgA deficiency
Castigli, E., Wilson, S. A., Garibyan, L., Rachid, R., Bonilla, F., Schneider, L., & Geha, R. S. (2005) · Nature Genetics · doi:10.1038/ng1601 · Cited by 702
Multiple sclerosis: Geoepidemiology, genetics and the environment
Milo, R., & Kahana, E. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.11.010 · Cited by 680
New concepts in the generation and functions of IgA
Pabst, O. (2012) · Nature reviews. Immunology · doi:10.1038/nri3322 · Cited by 656
Kiryluk, K., Li, Y., Scolari, F., Sanna-Cherchi, S., Choi, M., Verbitsky, M., Fasel, D., Lata, S., Prakash, S., Shapiro, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.3118 · Cited by 628
Self-citationGenome-wide association study identifies susceptibility loci for IgA nephropathy
Gharavi, A. G., Kiryluk, K., Choi, M., Li, Y., Hou, P., Xie, J., Sanna-Cherchi, S., Men, C. J., Julian, B. A., Wyatt, R. J., et al. (2011) · Nature Genetics · doi:10.1038/ng.787 · Cited by 624
Self-citationHenoch-Scho[Combining Diaeresis]nlein Purpura in Adults: Outcome and Prognostic Factors
Pillebout, E., Thervet, E., Hill, G., Alberti, C., Vanhille, P., & Nochy, D. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000013883.99976.22 · Cited by 570
Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data
Tomino, Y. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000368458 · Cited by 566
Transglutaminase 2: an enigmatic enzyme with diverse functions
Fesus, L., & Piacentini, M. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02182-5 · Cited by 556
[Intercapillary deposits of IgA-IgG].
Berger, J., & Hinglais, N. (1968) · PubMed · Cited by 533
Corticosteroids in IgA nephropathy: a randomised controlled trial
Pozzi, C., Bolasco, P., Fogazzi, G., Andrulli, S., Altieri, P., Ponticelli, C., & Locatelli, F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03563-6 · Cited by 532
Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors
D’Amico, G. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.8966 · Cited by 499
Coppo, R., on behalf of the VALIGA study of the ERA-EDTA Immunonephrology Working Group, Troyanov, S., Bellur, S., Cattran, D., Cook, H. T., Feehally, J., Roberts, I. S. D., Morando, L., Camilla, R., et al. (2014) · Kidney International · doi:10.1038/ki.2014.63 · Cited by 498
Corticosteroid Effectiveness in IgA Nephropathy: Long-Term Results of a Randomized, Controlled Trial
Pozzi, C., Andrulli, S., Del Vecchio, L., Melis, P., Fogazzi, G. B., Altieri, P., Ponticelli, C., & Locatelli, F. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000103869.08096.4f · Cited by 484
Common variants at five new loci associated with early-onset inflammatory bowel disease
Western Regional Research Alliance for Pediatric IBD, Imielinski, M., International IBD Genetics Consortium, Baldassano, R. N., Griffiths, A., Russell, R. K., Annese, V., Dubinsky, M., Kugathasan, S., Bradfield, J. P., et al. (2009) · Nature Genetics · doi:10.1038/ng.489 · Cited by 482
Hughes, A. E., Orr, N., Esfandiary, H., Diaz-Torres, M., Goodship, T., & Chakravarthy, U. (2006) · Nature Genetics · doi:10.1038/ng1890 · Cited by 467
Suzuki, H., Fan, R., Zhang, Z., Brown, R., Hall, S., Julian, B. A., Chatham, W. W., Suzuki, Y., Wyatt, R. J., Moldoveanu, Z., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38468 · Cited by 450
Roos, A., Rastaldi, M. P., Calvaresi, N., Oortwijn, B. D., Schlagwein, N., van Gijlswijk-Janssen, D. J., Stahl, G. L., Matsushita, M., Fujita, T., van Kooten, C., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090923 · Cited by 450
Predicting renal outcome in IgA nephropathy.
Radford, M. G., Donadio, J. V., Bergstralh, E. J., & Grande, J. P. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v82199 · Cited by 440
Impaired IgA class switching in APRIL-deficient mice
Castigli, E., Scott, S., Dedeoglu, F., Bryce, P., Jabara, H., Bhan, A. K., Mizoguchi, E., & Geha, R. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307348101 · Cited by 432
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels
Moldoveanu, Z., Wyatt, R. J., Lee, J. Y., Tomana, M., Julian, B. A., Mestecky, J., Huang, W.-Q., Anreddy, S. R., Hall, S., Hastings, M. C., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002185 · Cited by 422
Deep Dermatophytosis and Inherited CARD9 Deficiency
Lanternier, F., Pathan, S., Vincent, Q. B., Liu, L., Cypowyj, S., Prando, C., Migaud, M., Taibi, L., Ammar-Khodja, A., Boudghene Stambouli, O., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208487 · Cited by 400
Kiryluk, K., Li, Y., Sanna-Cherchi, S., Rohanizadegan, M., Suzuki, H., Eitner, F., Snyder, H. J., Choi, M., Hou, P., Scolari, F., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002765 · Cited by 383
Self-citationTreatment of IgA Nephropathy with ACE Inhibitors: A Randomized and Controlled Trial
Praga, M., Gutiérrez, E., González, E., Morales, E., & Hernández, E. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000068460.37369.dc · Cited by 345
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23
Gharavi, A. G., Yan, Y., Scolari, F., Schena, F. P., Frasca, G. M., Ghiggeri, G. M., Cooper, K., Amoroso, A., Viola, B. F., Battini, G. G., et al. (2000) · Nature Genetics · doi:10.1038/81677 · Cited by 332
Natural history and risk factors for immunoglobulin a nephropathy in Japan
Koyama, A., Igarashi, M., & Kobayashi, M. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90333-4 · Cited by 326
Zipfel, P. F., Edey, M., Heinen, S., Józsi, M., Richter, H., Misselwitz, J., Hoppe, B., Routledge, D., Strain, L., Hughes, A. E., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030041 · Cited by 325
Matysiak-Budnik, T., Moura, I. C., Arcos-Fajardo, M., Lebreton, C., Ménard, S., Candalh, C., Ben-Khalifa, K., Dugave, C., Tamouza, H., van Niel, G., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071204 · Cited by 313
Yu, X.-Q., Li, M., Zhang, H., Low, H.-Q., Wei, X., Wang, J.-Q., Sun, L.-D., Sim, K.-S., Li, Y., Foo, J.-N., et al. (2012) · Nature Genetics · doi:10.1038/ng.1047 · Cited by 312
Manno, C., Torres, D. D., Rossini, M., Pesce, F., & Schena, F. P. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp356 · Cited by 311
Incidence of latent mesangial IgA deposition in renal allograft donors in Japan
Suzuki, K., Honda, K., Tanabe, K., Toma, H., Nihei, H., & Yamaguchi, Y. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.6s.2.x · Cited by 296
Moura, I. C., Centelles, M. N., Arcos-Fajardo, M., Malheiros, D. M., Collawn, J. F., Cooper, M. D., & Monteiro, R. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.417 · Cited by 293
Dimerization of complement factor H-related proteins modulates complement activation in vivo
Goicoechea de Jorge, E., Caesar, J. J. E., Malik, T. H., Patel, M., Colledge, M., Johnson, S., Hakobyan, S., Morgan, B. P., Harris, C. L., Pickering, M. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219260110 · Cited by 289
Mice overexpressing BAFF develop a commensal flora–dependent, IgA-associated nephropathy
McCarthy, D. D., Kujawa, J., Wilson, C., Papandile, A., Poreci, U., Porfilio, E. A., Ward, L., Lawson, M. A. E., Macpherson, A. J., McCoy, K. D., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45563 · Cited by 286
Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy
Gharavi, A. G., Moldoveanu, Z., Wyatt, R. J., Barker, C. V., Woodford, S. Y., Lifton, R. P., Mestecky, J., Novak, J., & Julian, B. A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091052 · Cited by 284
HLA Has Strongest Association with IgA Nephropathy in Genome-Wide Analysis
Feehally, J., Farrall, M., Boland, A., Gale, D. P., Gut, I., Heath, S., Kumar, A., Peden, J. F., Maxwell, P. H., Morris, D. L., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010076 · Cited by 281
Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy
ALLEN, A. C., HARPER, S. J., & FEEHALLY, J. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03724.x · Cited by 277
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1
Suzuki, H., Moldoveanu, Z., Hall, S., Brown, R., Vu, H. L., Novak, L., Julian, B. A., Tomana, M., Wyatt, R. J., Edberg, J. C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33189 · Cited by 277
Wu, F., Dassopoulos, T., Cope, L., Maitra, A., Brant, S. R., Harris, M. L., Bayless, T. M., Parmigiani, G., & Chakravarti, S. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20110 · Cited by 272
Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy
Berthoux, F., Suzuki, H., Thibaudin, L., Yanagawa, H., Maillard, N., Mariat, C., Tomino, Y., Julian, B. A., & Novak, J. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010053 · Cited by 272
The geoepidemiology of type 1 diabetes
Borchers, A. T., Uibo, R., & Gershwin, M. E. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.12.003 · Cited by 268
Kiryluk, K., Moldoveanu, Z., Sanders, J. T., Eison, T. M., Suzuki, H., Julian, B. A., Novak, J., Gharavi, A. G., & Wyatt, R. J. (2011) · Kidney International · doi:10.1038/ki.2011.16 · Cited by 266
Self-citationRoberts, I. S. D. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.92 · Cited by 263
Defining and analyzing geoepidemiology and human autoimmunity
Shapira, Y., Agmon-Levin, N., & Shoenfeld, Y. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.018 · Cited by 260
APRIL modulates B and T cell immunity
Stein, J. V., López-Fraga, M., Elustondo, F. A., Carvalho-Pinto, C. E., Rodríguez, D., Gómez-Caro, R., de Jong, J., Martínez-A, C., Medema, J. P., & Hahne, M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15034 · Cited by 258
Coppo (2007) · doi:10.1681/asn.2006040347 · Cited by 256
Zhao, N., Hou, P., Lv, J., Moldoveanu, Z., Li, Y., Kiryluk, K., Gharavi, A. G., Novak, J., & Zhang, H. (2012) · Kidney International · doi:10.1038/ki.2012.197 · Cited by 248
Self-citationRusso, D., Pisani, A., Balletta, M. M., De Nicola, L., Savino, F. A., Andreucci, M., & Minutolo, R. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70416-6 · Cited by 243
Schena, F. P. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.3.418 · Cited by 242
Microbiota and Metabolome Associated with Immunoglobulin A Nephropathy (IgAN)
De Angelis, M., Montemurno, E., Piccolo, M., Vannini, L., Lauriero, G., Maranzano, V., Gozzi, G., Serrazanetti, D., Dalfino, G., Gobbetti, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099006 · Cited by 239
Zhao, J., Wu, H., Khosravi, M., Cui, H., Qian, X., Kelly, J. A., Kaufman, K. M., Langefeld, C. D., Williams, A. H., Comeau, M. E., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002079 · Cited by 231
Bertin, J., Guo, Y., Wang, L., Srinivasula, S. M., Jacobson, M. D., Poyet, J.-L., Merriam, S., Du, M.-Q., Dyer, M. J. S., Robison, K. E., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000726200 · Cited by 231
APRIL modulates B and T cell immunity
Stein, J. V., López-Fraga, M., Elustondo, F. A., Carvalho-Pinto, C. E., Rodríguez, D., Gómez-Caro, R., de Jong, J., Martínez-A, C., Medema, J. P., & Hahne, M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215034 · Cited by 229
Ernst, M., Inglese, M., Waring, P., Campbell, I. K., Bao, S., Clay, F. J., Alexander, W. S., Wicks, I. P., Tarlinton, D. M., Novak, U., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.2.189 · Cited by 227
The genetics and immunobiology of IgA nephropathy
Kiryluk, K., & Novak, J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74475 · Cited by 224
Self-citationLi, P. K.-T., Leung, C. B., Chow, K. M., Cheng, Y. L., Fung, S. K.-S., Mak, S. K., Tang, A. W.-C., Wong, T. Y.-H., Yung, C. Y., Yung, J. C.-U., et al. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.01.017 · Cited by 223
Pathogenesis of IgA nephropathy
Lai, K. N. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.58 · Cited by 221
Association of C4d Deposition with Clinical Outcomes in IgA Nephropathy
Espinosa, M., Ortega, R., Sánchez, M., Segarra, A., Salcedo, M. T., González, F., Camacho, R., Valdivia, M. A., Cabrera, R., López, K., et al. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09710913 · Cited by 218
Beaudoin, M., Goyette, P., Boucher, G., Lo, K. S., Rivas, M. A., Stevens, C., Alikashani, A., Ladouceur, M., Ellinghaus, D., Törkvist, L., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003723 · Cited by 212
Validation of the Oxford classification of IgA nephropathy
Herzenberg, A. M., Fogo, A. B., Reich, H. N., Troyanov, S., Bavbek, N., Massat, A. E., Hunley, T. E., Hladunewich, M. A., Julian, B. A., Fervenza, F. C., et al. (2011) · Kidney International · doi:10.1038/ki.2011.126 · Cited by 211
Coppo, R., Troyanov, S., Camilla, R., Hogg, R. J., Cattran, D. C., Terence Cook, H., Feehally, J., Roberts, I. S. D., Amore, A., Alpers, C. E., et al. (2010) · Kidney International · doi:10.1038/ki.2010.43 · Cited by 204
Self-citationC3 glomerulopathy–associated CFHR1 mutation alters FHR oligomerization and complement regulation
Tortajada, A., Yébenes, H., Abarrategui-Garrido, C., Anter, J., García-Fernández, J. M., Martínez-Barricarte, R., Alba-Domínguez, M., Malik, T. H., Bedoya, R., Pérez, R. C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68280 · Cited by 197
Corticosteroid therapy in IgA nephropathy
Lv, J., Xu, D., Perkovic, V., Ma, X., Johnson, D. W., Woodward, M., Levin, A., Zhang, H., & Wang, H. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111112 · Cited by 190
Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No Proteinuria
Gutiérrez, E., Zamora, I., Ballarín, J. A., Arce, Y., Jiménez, S., Quereda, C., Olea, T., Martínez-Ara, J., Segarra, A., Bernis, C., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010063 · Cited by 185
The Italian experience of the national registry of renal biopsies
Gesualdo, L., Di Palma, A. M., Morrone, L. F., Strippoli, G. F., & Schena, F. P. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00831.x · Cited by 184
Moura, I. C., Arcos-Fajardo, M., Sadaka, C., Leroy, V., Benhamou, M., Novak, J., Vrtovsnik, F. C., Haddad, E., Chintalacharuvu, K. R., & Monteiro, R. C. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000115401.07980.0c · Cited by 182
Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
Berthelot, L., Papista, C., Maciel, T. T., Biarnes-Pelicot, M., Tissandie, E., Wang, P. H. M., Tamouza, H., Jamin, A., Bex-Coudrat, J., Gestin, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112005 · Cited by 182
Evaluation of the Oxford Classification of IgA Nephropathy: A Systematic Review and Meta-analysis
Lv, J., Shi, S., Xu, D., Zhang, H., Troyanov, S., Cattran, D. C., & Wang, H. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.04.021 · Cited by 177
Schmidt, N., Gonzalez, E., Visekruna, A., Kühl, A. A., Loddenkemper, C., Mollenkopf, H., Kaufmann, S. H. E., Steinhoff, U., & Joeris, T. (2010) · Gut · doi:10.1136/gut.2009.203554 · Cited by 166
An update on the pathogenesis and treatment of IgA nephropathy
Boyd, J. K., Cheung, C. K., Molyneux, K., Feehally, J., & Barratt, J. (2012) · Kidney International · doi:10.1038/ki.2011.501 · Cited by 164
Zhu, L., Zhai, Y.-L., Wang, F.-M., Hou, P., Lv, J.-C., Xu, D.-M., Shi, S.-F., Liu, L.-J., Yu, F., Zhao, M.-H., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010096 · Cited by 164
The Use of the Oxford Classification of IgA Nephropathy to Predict Renal Survival
Alamartine, E., Sauron, C., Laurent, B., Sury, A., Seffert, A., & Mariat, C. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01170211 · Cited by 162
Sokol, H., Conway, K. L., Zhang, M., Choi, M., Morin, B., Cao, Z., Villablanca, E. J., Li, C., Wijmenga, C., Yun, S. H., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.047 · Cited by 162
Visekruna, A., Joeris, T., Seidel, D., Kroesen, A., Loddenkemper, C., Zeitz, M., Kaufmann, S. H. E., Schmidt-Ullrich, R., & Steinhoff, U. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28804 · Cited by 159
Fujimoto, K., Karuppuchamy, T., Takemura, N., Shimohigoshi, M., Machida, T., Haseda, Y., Aoshi, T., Ishii, K. J., Akira, S., & Uematsu, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004036 · Cited by 159
Shweke, N., Boulos, N., Jouanneau, C., Vandermeersch, S., Melino, G., Dussaule, J., Chatziantoniou, C., Ronco, P. M., & Boffa, J. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080025 · Cited by 155
Sugiyama, H., Yokoyama, H., Satō, H., Saito, T., Kohda, Y., Nishi, S., Tsuruya, K., Kiyomoto, H., Iida, H., Sasaki, T., et al. (2011) · Clinical and Experimental Nephrology · doi:10.1007/s10157-011-0430-4 · Cited by 154
Predicting Progression of IgA Nephropathy: New Clinical Progression Risk Score
Xie, J., Kiryluk, K., Wang, W., Wang, Z., Guo, S., Shen, P., Ren, H., Pan, X., Chen, X., Zhang, W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038904 · Cited by 149
Self-citationAddition of Azathioprine to Corticosteroids Does Not Benefit Patients with IgA Nephropathy
Pozzi, C., Andrulli, S., Pani, A., Scaini, P., Vecchio, L. D., Fogazzi, G., Vogt, B., Cristofaro, V. D., Allegri, L., Cirami, L. C., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010117 · Cited by 143
Novel Associations for Hypothyroidism Include Known Autoimmune Risk Loci
Eriksson, N., Tung, J. Y., Kiefer, A. K., Hinds, D. A., Francke, U., Mountain, J. L., & Do, C. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034442 · Cited by 142
Smerud, H. K., Barany, P. F., Lindstrom, K., Fernström, A., Sandell, A., Påhlsson, P., & Fellström, B. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr052 · Cited by 139
A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases
Yanagawa, H., Suzuki, H., Suzuki, Y., Kiryluk, K., Gharavi, A. G., Matsuoka, K., Makita, Y., Julian, B. A., Novák, J., & Tomino, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098081 · Cited by 138
Self-citationIgA Nephropathy: Molecular Mechanisms of the Disease
Mestecky, J. F., Raška, M., Julian, B. A., Gharavi, A. G., Renfrow, M. B., Moldoveanu, Z., Novak, L., Matoušovic, K., & Novák, J. (2012) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130216 · Cited by 137
Glycosylation of IgA1 and pathogenesis of IgA nephropathy
Novák, J., Julian, B. A., Mestecky, J. F., & Renfrow, M. B. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0306-z · Cited by 130
Pathogenesis of Immunoglobulin A Nephropathy: Recent Insight from Genetic Studies
Kiryluk, K., Novák, J., & Gharavi, A. G. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-041811-142014 · Cited by 130
Self-citationMoura, I. C., Arcos‐Fajardo, M., Gdoura, A., Leroy, V. A. A., Sadaka, C., Mahlaoui, N., Lepelletier, Y., Vrtovsnik, F., Haddad, É., Benhamou, M., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004111006 · Cited by 128
Paterson, A. D., Liu, X.-Q., Wang, K., Magistroni, R., Song, X., Kappel, J. E., Klassen, J., Cattran, D., George‐Hyslop, P. S., & Pei, Y. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007020241 · Cited by 127
Self-citationOkpechi, I., Swanepoel, C. R., Duffield, M., Mahala, B. K., Wearne, N., Alagbe, S. C., Barday, Z., Arendse, C. G., & Rayner, B. L. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq655 · Cited by 126
Epidemiology of idiopathic glomerular disease: A prospective study
Tiebosch, A. T. M. G., Wolters, J., Frederik, P. M., van der Wiel, T. W. M., Zeppenfeldt, E., Vriesman, P. J. C. V. B., & van Rie, H. (1987) · Kidney International · doi:10.1038/ki.1987.179 · Cited by 112
O-Glycosylation of Serum IgD in IgA Nephropathy
Smith, A. C., de Wolff, J. F., Molyneux, K., Feehally, J., & Barratt, J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101115 · Cited by 104
Genetic studies of IgA nephropathy: past, present, and future
Kiryluk, K., Julian, B. A., Wyatt, R. J., Scolari, F., Zhang, H., Novák, J., & Gharavi, A. G. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1500-7 · Cited by 96
Self-citationGenetic and environmental factors and the distribution of multiple sclerosis in Europe
Handel, A. E., Handunnetthi, L., Giovannoni, G., Ebers, G. C., & Ramagopalan, S. V. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03003.x · Cited by 89
Familial clustering of IgA nephropathy: Further evidence in an Italian population
Scolari, F., Amoroso, A., Savoldi, S., Mazzola, G. A., Prati, E., Valzorio, B., Viola, B. F., Bossini, N., Movilli, E., Sandrini, M., et al. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70417-8 · Cited by 88
Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy
Harper, S. J., Pringle, J. H., Wicks, A. C. B., Hattersley, J., Layward, L., Allen, A., Gillies, A., Lauder, I. J., & Feehally, J. (1994) · Kidney International · doi:10.1038/ki.1994.110 · Cited by 85
Galactose-Deficient IgA1 in African Americans with IgA Nephropathy
Hastings, M. C., Moldoveanu, Z., Julian, B. A., Novák, J., Sanders, J. T., McGlothan, K. R., Gharavi, A. G., & Wyatt, R. J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03270410 · Cited by 81
Mac-1 (CD11b/CD18) as Accessory Molecule for FcαR (CD89) Binding of IgA
van Spriel, A. B., Leusen, J. H. W., Vilé, H. A., & van de Winkel, J. G. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3831 · Cited by 80
Global trends in neglected tropical disease control and elimination: impact on child health
Barry, M. A., Simon, G. G., Mistry, N., & Hotez, P. J. (2013) · Archives of Disease in Childhood · doi:10.1136/archdischild-2012-302338 · Cited by 76
Kataoka, H., Ohara, M., Shibui, K., Sato, M., Suzuki, T., Amemiya, N., Watanabe, Y., Honda, K., Mochizuki, T., & Nitta, K. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-012-0613-7 · Cited by 73
Mortality in Patients With IgA Nephropathy
Knoop, T., Vikse, B. E., Svarstad, E., Leh, S. M., Reisæter, A. V., & Bjørneklett, R. O. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.04.019 · Cited by 70
Haas, M., Rastaldi, M. P., & Fervenza, F. C. (2013) · Kidney International · doi:10.1038/ki.2013.375 · Cited by 64
New insights into the pathogenesis of IgA nephropathy
Floege, J., Moura, I. C., & Daha, M. R. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-013-0411-7 · Cited by 62
T-cell homing receptor expression in IgA nephropathy
Batra, A., Smith, A. C., Feehally, J., & Barratt, J. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm228 · Cited by 53
Epidemiology of glomerulonephritis in Northern Germany
Braun, N., Schweisfurth, A., Lohöfener, C., Lange, C., Gründemann, C., Kundt, G., & Gröne, H. (2011) · International Urology and Nephrology · doi:10.1007/s11255-011-9955-4 · Cited by 51
Vav proteins regulate peripheral B-cell survival
Vigorito, E., Gambardella, L., Colucci, F., McAdam, S., & Turner, M. (2005) · Blood · doi:10.1182/blood-2004-12-4894 · Cited by 50
Long-term prognosis of clinically early IgA nephropathy is not always favorable
Lee, H., Hwang, J. H., Paik, J. H., Ryu, H. J., Kim, D. K., Chin, H. J., Oh, Y. K., Joo, K. W., Lim, C. S., Kim, Y. S., et al. (2014) · BMC Nephrology · doi:10.1186/1471-2369-15-94 · Cited by 48
Osman, W. M., Okada, Y., Kamatani, Y., Kubo, M., Matsuda, K., & Nakamura, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032683 · Cited by 40
Guimbaud, R., Abitbol, V., Bertrand, V., Quartier, G., Chauvelot‐Moachon, L., Giroud, J., Couturier, D., & Chaussade, D. C. (1998) · PubMed · Cited by 39
Renal diseases: a 27-year renal biopsy study
Carvalho, E., Faria, M. D. S., Nunes, J. P. L., Sampaio-Norton, S., & Valbuena, C. (2006) · Journal of Nephrology · doi:10.1093/joneph/19.4.500 · Cited by 39
IgA Nephropathy: Progress Before and Since Berger
Feehally, J., & Cameron, J. S. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.03.024 · Cited by 36
Kalabis, J., Patterson, M. J., Enders, G. H., Marian, B., Iozzo, R. V., Rogler, G., Gimotty, P. A., & Herlyn, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0852fje · Cited by 33
Esashi, E., Ito, H., Minehata, K., Saito, S., Morikawa, Y., & Miyajima, A. (2009) · European Journal of Immunology · doi:10.1002/eji.200839149 · Cited by 32
IgA Nephropathy: A Disease in Search of a Large-Scale Clinical Trial to Reliably Inform Practice
Strippoli, G. F., Maione, A., Schena, F. P., Tognoni, G., & Craig, J. C. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.10.035 · Cited by 28
Vav proteins are necessary for correct differentiation of mouse cecal and colonic enterocytes
Liu, J. Y., Seno, H., Miletic, A. V., Mills, J. C., Swat, W., & Stappenbeck, T. S. (2009) · Journal of Cell Science · doi:10.1242/jcs.033720 · Cited by 25
Renal biopsy findings in Belgium: a retrospective single center analysis.
Mesquita, M., Fosso, C., Sol, E. B., Libertalis, M., Corazza, F., Houte, K. V., & Dratwa, M. (2011) · PubMed · doi:10.2143/acb.66.2.2062527 · Cited by 23
Levison, S., Fisher, P., Hankinson, J., Zeef, L. A. H., Eyre, S., Ollier, W., McLaughlin, J. T., Brass, A., Grencis, R. K., & Pennock, J. L. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-127 · Cited by 21
Enhanced Expression of CD31 and CD54 on Tonsillar High Endothelial Venules in IgA Nephropathy
March, A. K.-D., Béné, M. C., de Ligny, B. H., Kessler, M., & Faure, G. C. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4389 · Cited by 17
Discordant clinicopathological features in monozygotic twins with IgA nephropathy
Tsuboi, N., Kawamura, T., Okonogi, H., Ishii, T., Utsunomiya, Y., & Hosoya, T. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr519 · Cited by 7
Distribution of renal histopathology in Guilan: a single-center report.
Monfared, A., Khosravi, M., Lebadi, M., Zamir, S. A. M. R., Hoda, S., Habibzadeh, S. M., & Besharati, S. (2012) · Iranian Journal of Kidney Diseases · Cited by 6
[Epidemiology of primary glomerulonephritis in Picardie].
Abdulmassih, Z., Makdassi, R., Bove, N., Lalau, J., Lambrey, G., Coevoet, B., Fievet, P., Bataille, P., Renaud, H., & Westeel, P. F. (1990) · PubMed · Cited by 5
Cited by
Rodrigues, J. C., Haas, M., & Reich, H. N. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07420716 · Cited by 555
Hayashi, K., Hishikawa, A., Hashiguchi, A., Azegami, T., Yoshimoto, N., Nakamichi, R., Tokuyama, H., & Itoh, H. (2020) · Scientific Reports · doi:10.1038/s41598-019-57140-0 · Cited by 25
Metadata
- Authors
- Magistroni, R., D’Agati, V. D., Appel, G. B., & Kiryluk, K.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 88
- Issue
- 5
- Pages
- 974-989
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2212745154
- Cited by
- 302
- References
- 139
- FWCI
- 17.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.